Intravitreal Dexamethasone Implant as a Sustained Release Drug Delivery Device for the Treatment of Ocular Diseases: A Comprehensive Review of the Literature

Intravitreal Dexamethasone Implant as a Sustained Release Drug Delivery Device for the Treatment of Ocular Diseases: A Comprehensive Review of the Literature

Drug delivery into the vitreous chamber remains a great challenge in the pharmaceutical industry due to the complex anatomy and physiology of the eye. Intravitreal injection is the mainstream route of drug administration to the posterior segment of the eye. The purpose of this review is to assess th...

Full description

Bibliographic Details
Main Authors: Claudio Iovino, Rodolfo Mastropasqua, Marco Lupidi, Daniela Bacherini, Marco Pellegrini, Federico Bernabei, Enrico Borrelli, Riccardo Sacconi, Adriano Carnevali, Rossella D’Aloisio, Alessio Cerquaglia, Lucia Finocchio, Andrea Govetto, Stefano Erba, Giacinto Triolo, Antonio Di Zazzo, Matteo Forlini, Aldo Vagge, Giuseppe Giannaccare
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Pharmaceutics
Subjects:
corticosteroids
drug delivery systems
intravitreal dexamethasone implant
intravitreal injections
Ozurdex
Online Access:https://www.mdpi.com/1999-4923/12/8/703

Internet

https://www.mdpi.com/1999-4923/12/8/703

Similar Items